Modulation of chemokine receptor activity through dimerization and crosstalk

被引:69
作者
Salanga, C. L. [1 ]
O'Hayre, M. [1 ]
Handel, T. [1 ]
机构
[1] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
关键词
Chemokine; chemokine receptor; dimerization; crosstalk; synergy; signal transduction; PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR RECEPTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; CELL SIGNALING PATHWAYS; EPITHELIAL-CELLS; HIV-1; INFECTION; MOLECULAR-BASIS; CANCER CELLS; HETEROLOGOUS DESENSITIZATION;
D O I
10.1007/s00018-008-8666-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines are small, secreted proteins that bind to the chemokine receptor subfamily of class A G protein-coupled receptors. Collectively, these receptor-ligand pairs are responsible for diverse physiological responses including immune cell trafficking, development and mitogenic signaling, both in the context of homeostasis and disease. However, chemokines and their receptors are not isolated entities, but instead function in complex networks involving homo- and heterodimer formation as well as crosstalk with other signaling complexes. Here the functional consequences of chemokine receptor activity, from the perspective of both direct physical associations with other receptors and indirect crosstalk with orthogonal signaling pathways, are reviewed. Modulation of chemokine receptor activity through these mechanisms has significant implications in physiological and pathological processes, as well as drug discovery and drug efficacy. The integration of signals downstream of chemokine and other receptors will be key to understanding how cells fine-tune their response to a variety of stimuli, including therapeutics.
引用
收藏
页码:1370 / 1386
页数:17
相关论文
共 115 条
[1]   Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells [J].
Adachi, T ;
Cui, CH ;
Kanda, A ;
Kayaba, H ;
Ohta, K ;
Chihara, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (02) :292-296
[2]   Role for CCR5Δ32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells [J].
Agrawal, L ;
Lu, XH ;
Qingwen, J ;
VanHorn-Ali, Z ;
Nicolescu, IV ;
McDermott, DH ;
Murphy, PM ;
Alkhatib, G .
JOURNAL OF VIROLOGY, 2004, 78 (05) :2277-2287
[3]   Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells [J].
Akekawatchai, C ;
Holland, JD ;
Kochetkova, M ;
Wallace, JC ;
McColl, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) :39701-39708
[4]   Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells [J].
AlAoukaty, A ;
Schall, TJ ;
Maghazachi, AA .
BLOOD, 1996, 87 (10) :4255-4260
[5]   Chemokine: Receptor structure, interactions, and antagonism [J].
Allen, Samantha J. ;
Crown, Susan E. ;
Handel, Tracy M. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :787-820
[6]   Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function [J].
Angers, S ;
Salahpour, A ;
Bouvier, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :409-435
[7]   Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor [J].
Babcock, GJ ;
Farzan, M ;
Sodroski, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3378-3385
[8]   ACTIVATION OF DUAL T-CELL SIGNALING PATHWAYS BY THE CHEMOKINE RANTES [J].
BACON, KB ;
PREMACK, BA ;
GARDNER, P ;
SCHALL, TJ .
SCIENCE, 1995, 269 (5231) :1727-1730
[9]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[10]   WHIM4 syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 [J].
Balabanian, K ;
Lagane, B ;
Pablos, JL ;
Laurent, L ;
Planchenault, T ;
Verola, O ;
Lebbe, C ;
Kerob, D ;
Dupuy, A ;
Hermine, O ;
Nicolas, JF ;
Latger-Cannard, W ;
Bensoussan, D ;
Bordigoni, P ;
Baleux, F ;
Le Deist, F ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Bachelerie, F .
BLOOD, 2005, 105 (06) :2449-2457